Skip to main content

NIV-145 180 mg Pill - red & white capsule/oblong, 19mm

Pill with imprint NIV-145 180 mg is Red & White, Capsule/Oblong and has been identified as Temozolomide 180 mg. It is supplied by Nivagen Pharmaceuticals, Inc.

Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NIV-145 180 mg


NIV-145 180 mg
180 mg
Red & White
19.00 mm
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Nivagen Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose anhydrous, silicon dioxide, sodium starch glycolate type A potato, tartaric acid, stearic acid, gelatin, titanium dioxide, ferric oxide red, shellac, butyl alcohol, isopropyl alcohol, propylene glycol, ammonia, potassium hydroxide, ferrosoferric oxide, water, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.